Abbott Laboratories

Sector and Industry

Healthcare, Healthcare Equipment

Performance (1Y)

31.33%

Market Cap

135.51 Bil.

P/E Ratio

33.69

Dividend Yield

1.92 %

Earnings per Share

3.30 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Abbott Laboratories185.26 Bil.39.29 Bil.33.69
-53.32 %
0.00
-
Intuitive Surgical Inc171.24 Bil.8.92 Bil.71.93
+17.90 %
0.00
-
Boston Scientific Corp120.40 Bil.17.79 Bil.49.17
+49.88 %
0.00
-
Stryker Corp.114.47 Bil.22.26 Bil.41.85
+3.99 %
0.00
-
Medtronic PLC90.93 Bil.31.27 Bil.22.35
-4.61 %
0.00
-
Siemens Healthineers AG51.40 Bil.23.38 Bil.24.04
+10.40 %
0.00
-
Hoya Corp48.59 Bil.5.43 Bil.35.69
+17.33 %
0.00
-
Becton Dickinson and Co.45.46 Bil.19.79 Bil.32.18
-3.33 %
0.00
-
Edwards Lifesciences Corp42.15 Bil.5.38 Bil.47.11
-27.44 %
0.00
-
Alcon AG33.20 Bil.9.24 Bil.38.41
-7.56 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE86 G0 Units
PRICE DETERMINATION TIME07/16/2026 / 09:57:00 PM
DAILY VOLUME (UNITS)1,176
DAILY HIGH / LOW87.3677.56
PREV. DAY'S PRICE77.8 (07/15)
CHANGE DAY BEFORE
+8.20
10.54 %
52 WEEK HIGH / LOW116.32 (09/22)69.64 (05/11)

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
3.027.063.304.785.29
DIVIDENDS PER SHARE
1.922.072.132.212.36
DIVIDEND YIELD IN %
1.89 %1.98 %1.92 %--
DIVIDEND GROWTH IN %
5.37 %7.63 %2.73 %--
PRICE - EARNINGS RATIO
33.7714.8133.6916.2614.70
PRICE - BOOK RATIO
4.944.114.17--
PRICE - SALES RATIO
4.804.714.94--
PRICE - CASH FLOW RATIO
26.5123.1022.89--
Further Key Figures

Master Data

WKN
850103
ISIN
US0028241000
SYMBOL
ABL
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
Abbott Laboratories
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
US Dollar
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Healthcare Equipment
NUMBER OF SHARES
1.74 Bil.
MARKET CAPITALISATION
135.51 Bil.

Performance overview

1W1M3M6M1Y3Y5YYTD
Performance
-6.58 %
1.73 %
-9.43 %
-26.82 %
-31.33 %
-19.41 %
-21.06 %
-26.23 %
High83.1485.6287.08106.22116.32134.10134.10110.38
Low77.0876.2269.6469.6469.6469.6469.6469.64

Dividende

pro Aktie

Company profile

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment focuses on branded generic pharmaceuticals that are manufactured worldwide and marketed and sold outside the United States, primarily in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternative care testing sites. The Nutritional Products segment oversees the worldwide sale of pediatric and adult nutritional products. The Medical Devices segment offers a broad range of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, as well as diabetes care and continuous glucose monitoring products. It also provides neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.